CIK 0001082554
- Large accelerated filer
UNITED THERAPEUTICS Corp
Sign in to watch- Ticker
- UTHR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 521984749
- Phone
- +1 301-608-9292
- Business address
- 1000 SPRING ST, SILVER SPRING, MD, 20910
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $344,206,005
- in 74 filings, $343.4M under 10b5-1 plans
Net −$344,206,005. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-11-17 | EDGEMOND JAMES CFO AND TREASURER | Exercise or conversion 10b5-1 | +10,688 | $146.03 | $1.6M | 18,806 |
| 2025-11-17 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −3,591 | $470.34 | $1.7M | 15,215 |
| 2025-11-17 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −2,657 | $471.22 | $1.3M | 12,558 |
| 2025-11-17 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −1,999 | $472.13 | $944K | 10,559 |
| 2025-11-17 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −920 | $473.68 | $436K | 9,639 |
| 2025-11-17 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −639 | $474.80 | $303K | 9,000 |
| 2025-11-17 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −798 | $475.89 | $380K | 8,202 |
| 2025-11-17 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −84 | $476.47 | $40K | 8,118 |
| 2025-11-17 | EDGEMOND JAMES CFO AND TREASURER | Exercise or conversion 10b5-1 | +10,312 | $146.03 | $1.5M | 18,430 |
| 2025-11-17 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −120 | $464.38 | $56K | 18,310 |
| 2025-11-17 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −1,090 | $467.53 | $510K | 17,220 |
| 2025-11-17 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −4,107 | $468.33 | $1.9M | 13,113 |
| 2025-11-17 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −4,558 | $469.39 | $2.1M | 8,555 |
| 2025-11-17 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −437 | $470.34 | $206K | 8,118 |
| 2025-11-17 | EDGEMOND JAMES CFO AND TREASURER | Exercise or conversion · Stock Option 10b5-1 | −10,312 | 0 | ||
| 2025-11-17 | EDGEMOND JAMES CFO AND TREASURER | Exercise or conversion · Stock Option 10b5-1 | −10,688 | 21,517 | ||
| 2025-11-17 | ROTHBLATT MARTINE A Chairperson & CEO | Exercise or conversion 10b5-1 | +4,000 | $120.26 | $481K | 4,130 |
| 2025-11-17 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,500 | $466.26 | $699K | 2,630 |
| 2025-11-17 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −2,500 | $468.32 | $1.2M | 130 |
| 2025-11-17 | ROTHBLATT MARTINE A Chairperson & CEO | Exercise or conversion · Stock Option 10b5-1 | −4,000 | 90,000 |
Page 181 of 214 · 4,273 trades